231 related articles for article (PubMed ID: 29142974)
1. Profiling of Plasma Metabolites Suggests Altered Mitochondrial Fuel Usage and Remodeling of Sphingolipid Metabolism in Individuals With Type 2 Diabetes and Kidney Disease.
Liu JJ; Ghosh S; Kovalik JP; Ching J; Choi HW; Tavintharan S; Ong CN; Sum CF; Summers SA; Tai ES; Lim SC
Kidney Int Rep; 2017 May; 2(3):470-480. PubMed ID: 29142974
[TBL] [Abstract][Full Text] [Related]
2. Impaired Amino Acid Metabolism and Its Correlation with Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus.
Zhu H; Bai M; Xie X; Wang J; Weng C; Dai H; Chen J; Han F; Lin W
Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014850
[TBL] [Abstract][Full Text] [Related]
3. Urinary sphingolipids in adolescents and young adults with youth-onset diabetes.
Nehus EJ; Sheanon NM; Zhang W; Marcovina SM; Setchell KDR; Mitsnefes MM
Pediatr Nephrol; 2024 Jun; 39(6):1875-1883. PubMed ID: 38172468
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic Signature of Diabetic Kidney Disease in Cerebrospinal Fluid and Plasma of Patients with Type 2 Diabetes Using Liquid Chromatography-Mass Spectrometry.
Lin HT; Cheng ML; Lo CJ; Lin G; Liu FC
Diagnostics (Basel); 2022 Oct; 12(11):. PubMed ID: 36359470
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic Profiling of Amino Acids in Human Plasma Distinguishes Diabetic Kidney Disease From Type 2 Diabetes Mellitus.
Zhou C; Zhang Q; Lu L; Wang J; Liu D; Liu Z
Front Med (Lausanne); 2021; 8():765873. PubMed ID: 34912824
[No Abstract] [Full Text] [Related]
6. Serum and Urinary Progranulin in Diabetic Kidney Disease.
Nicoletto BB; Krolikowski TC; Crispim D; Canani LH
PLoS One; 2016; 11(10):e0165177. PubMed ID: 27776152
[TBL] [Abstract][Full Text] [Related]
7. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
[TBL] [Abstract][Full Text] [Related]
8. Urine metabolomics reveals biomarkers and the underlying pathogenesis of diabetic kidney disease.
Luo M; Zhang Z; Lu Y; Feng W; Wu H; Fan L; Guan B; Dai Y; Tang D; Dong X; Yun C; Hocher B; Liu H; Li Q; Yin L
Int Urol Nephrol; 2023 Apr; 55(4):1001-1013. PubMed ID: 36255506
[TBL] [Abstract][Full Text] [Related]
9. Serum metabolomics detected by LDI-TOF-MS can be used to distinguish between diabetic patients with and without diabetic kidney disease.
Qian F; Zhao L; Zhang D; Yu M; Zhou W; Jin J
FEBS Open Bio; 2023 Oct; 13(10):1844-1858. PubMed ID: 37525631
[TBL] [Abstract][Full Text] [Related]
10. Metabolomic profiling of amino acids study reveals a distinct diagnostic model for diabetic kidney disease.
Wang J; Zhou C; Zhang Q; Liu Z
Amino Acids; 2023 Nov; 55(11):1563-1572. PubMed ID: 37736814
[TBL] [Abstract][Full Text] [Related]
11. Real-World Diagnosis and Treatment of Diabetic Kidney Disease.
Rodriguez F; Lee DJ; Gad SS; Santos MP; Beetel RJ; Vasey J; Bailey RA; Patel A; Blais J; Weir MR; Dash R
Adv Ther; 2021 Aug; 38(8):4425-4441. PubMed ID: 34254257
[TBL] [Abstract][Full Text] [Related]
12. The association between thyroid dysfunction (TD) and diabetic kidney disease (DKD) in type 2 diabetes mellitus (T2DM).
Zheng M; Wang D; Chen L; Chen MN; Wang W; Ye SD
Int J Clin Pract; 2019 Sep; ():e13415. PubMed ID: 31508877
[TBL] [Abstract][Full Text] [Related]
13. Associations of Plasma Glucagon Levels with Estimated Glomerular Filtration Rate, Albuminuria and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.
Huang HX; Shen LL; Huang HY; Zhao LH; Xu F; Zhang DM; Zhang XL; Chen T; Wang XQ; Xie Y; Su JB
Diabetes Metab J; 2021 Nov; 45(6):868-879. PubMed ID: 33752319
[TBL] [Abstract][Full Text] [Related]
14. Targeted metabolomics as a tool for the diagnosis of kidney disease in Type II diabetes mellitus.
Abdelsattar S; Kasemy ZA; Elsayed M; Elrahem TA; Zewain SK
Br J Biomed Sci; 2021 Oct; 78(4):184-190. PubMed ID: 33656967
[No Abstract] [Full Text] [Related]
15. Metabolomics reveal mitochondrial and fatty acid metabolism disorders that contribute to the development of DKD in T2DM patients.
Li L; Wang C; Yang H; Liu S; Lu Y; Fu P; Liu J
Mol Biosyst; 2017 Oct; 13(11):2392-2400. PubMed ID: 28956034
[TBL] [Abstract][Full Text] [Related]
16. Low Serum Dehydroepiandrosterone Is Associated With Diabetic Kidney Disease in Men With Type 2 Diabetes Mellitus.
Zhang X; Xiao J; Li X; Cui J; Wang K; He Q; Liu M
Front Endocrinol (Lausanne); 2022; 13():915494. PubMed ID: 35784547
[TBL] [Abstract][Full Text] [Related]
17. Integration of metabolomics and peptidomics reveals distinct molecular landscape of human diabetic kidney disease.
Jiang X; Liu X; Qu X; Zhu P; Wo F; Xu X; Jin J; He Q; Wu J
Theranostics; 2023; 13(10):3188-3203. PubMed ID: 37351171
[TBL] [Abstract][Full Text] [Related]
18. The association of erythrocyte sedimentation rate, high-sensitivity C-reactive protein and diabetic kidney disease in patients with type 2 diabetes.
Guo S; Wang M; Yu Y; Yang Y; Zeng F; Sun F; Li Q; He M; Li Y; Wen J; Gong W; Zhang Z
BMC Endocr Disord; 2020 Jul; 20(1):103. PubMed ID: 32660469
[TBL] [Abstract][Full Text] [Related]
19. Serum Elabela/Toddler Levels Are Associated with Albuminuria in Patients with Type 2 Diabetes.
Zhang H; Gong D; Ni L; Shi L; Xu W; Shi M; Chen J; Ai Y; Zhang X
Cell Physiol Biochem; 2018; 48(3):1347-1354. PubMed ID: 30048993
[TBL] [Abstract][Full Text] [Related]
20. Metabolomic Assessment Reveals Alteration in Polyols and Branched Chain Amino Acids Associated With Present and Future Renal Impairment in a Discovery Cohort of 637 Persons With Type 1 Diabetes.
Tofte N; Suvitaival T; Trost K; Mattila IM; Theilade S; Winther SA; Ahluwalia TS; Frimodt-Møller M; Legido-Quigley C; Rossing P
Front Endocrinol (Lausanne); 2019; 10():818. PubMed ID: 31824430
[No Abstract] [Full Text] [Related]
[Next] [New Search]
